RESUMEN
The rapid evolution of the flow cytometry field, currently allowing the measurement of 30-50 parameters per cell, has led to a marked increase in deep multivariate information. Manual gating is insufficient to extract all this information. Therefore, multivariate analysis (MVA) methods have been developed to extract information and efficiently analyze the high-density multicolour flow cytometry (MFC) data. To aid interpretation, MFC data are often logarithmically transformed before MVA. We studied the consequences of different transformations of flow cytometry data in datasets containing negative intensities caused by background subtractions and spreading error, as logarithmic transformation of negative data is impossible. Transformations such as logicle or hyperbolic arcsine transformations allow linearity around zero, whereas higher (positive and negative) intensities are logarithmically transformed. To define the linear range, a parameter (or cofactor) must be chosen. We show how the chosen transformation parameter has great impact on the MVA results. In some cases, peak splitting is observed, producing two distributions around zero in an actual homogeneous population. This may be misinterpreted as the presence of multiple cell populations. Moreover, when performing arbitrary transformation before MVA analysis, biologically relevant and statistically significant information might be missed. We present a new algorithm, Optimal Transformation for flow cytometry data (OTflow), which uses various statistical methods to optimally choose the parameter of the transformation and prevent artifacts such as peak splitting. Arbitrary or unconsidered transformation can lead to wrong conclusions for the MVA cluster methods, dimensionality reduction methods, and classification methods. We recommend transformation of flow cytometry data by using OTflow-defined parameters estimated per channel, in order to prevent peak splitting and other artifacts in the data.
Asunto(s)
Algoritmos , Artefactos , Citometría de Flujo , Análisis MultivarianteRESUMEN
White blood cells protect the body against disease but may also cause chronic inflammation, auto-immune diseases or leukemia. There are many different white blood cell types whose identity and function can be studied by measuring their protein expression. Therefore, high-throughput analytical instruments were developed to measure multiple proteins on millions of single cells. The information-rich biochemistry information may only be fully extracted using multivariate statistics. Here we show an overview of the most essential steps for multivariate data analysis of single cell data. We used white blood cells (immunology) as a case study, but a similar approach may be used in environment or biotech research. The first step is analyzing the study design and subsequently formulating a research question. The three main designs are immunophenotyping (finding different cell types), cell activation and rare cell discovery. When preparing the data it is essential to consider the design and focus on the cell type of interest by removing all unwanted events. After pre-processing, the ten-thousands to millions of single cells per sample need to be converted into a cellular distribution. For immunophenotyping a clustering method such as Self-Organizing Maps is useful and for cell activation a model that describes the covariance such as Principal Component Analysis is useful. In rare cell discovery it is useful to first model all common cells and remove them to find the rare cells. Finally discriminant analysis based on the cellular distribution may highlight which cell (sub)types are different between groups.
Asunto(s)
Análisis de Datos , Proteómica , Análisis por Conglomerados , Análisis Multivariante , ProteínasRESUMEN
Flow Cytometry is an analytical technology to simultaneously measure multiple markers per single cell. Ten thousands to millions of single cells can be measured per sample and each sample may contain a different number of cells. All samples may be bundled together, leading to a 'multi-set' structure. Many multivariate methods have been developed for Flow Cytometry data but none of them considers this structure in their quantitative handling of the data. The standard pre-processing used by existing multivariate methods provides models mainly influenced by the samples with more cells, while such a model should provide a balanced view of the biomedical information within all measurements. We propose an alternative 'multi-set' preprocessing that corrects for the difference in number of cells measured, balancing the relative importance of each multi-cell sample in the data while using all data collected from these expensive analyses. Moreover, one case example shows how multi-set pre-processing may benefit removal of undesired measurement-to-measurement variability and another where class-based multi-set pre-processing enhances the studied response upon comparison to the control reference samples. Our results show that adjusting data analysis algorithms to consider this multi-set structure may greatly benefit immunological insight and classification performance of Flow Cytometry data.
Asunto(s)
Procesamiento Automatizado de Datos/métodos , Citometría de Flujo/métodos , Análisis Multivariante , Algoritmos , Biomarcadores , Análisis de Datos , Humanos , Cómputos Matemáticos , Proyectos de InvestigaciónRESUMEN
Multicolour flow cytometry (MFC) is used to measure multiple cellular markers at the single-cell level. Cellular markers may be coloured with different panels of fluorescently-labelled antibodies to enable cell identification or the detection of activated cells in pre-defined, 'gated' specific cell subsets. The number of markers that can be used per measurement is technologically limited however, requiring every panel to be analysed in a separate aliquot measurement. The combined analyses of these dedicated panels may enhance the predictive ability of these measurements and could enrich the interpretation of the immunological information. Here we introduce a fusion method for MFC data, based on DAMACY (Discriminant Analysis of Multi-Aspect Cytometry data), which can combine information from complementary panels. This approach leads to both enhanced predictions and clearer interpretations in comparison with the analysis of separate measurements. We illustrate this method using two datasets: the response of neutrophils evoked by a systemic endotoxin challenge and the activated immune status of the innate cells, T cells and B cells in obese versus lean individuals. The data fusion approach was able to detect cells that do not individually show a difference between clinical phenotypes but do play a role in combination with other cells.
Asunto(s)
Biomarcadores/análisis , Citometría de Flujo/métodos , Inmunofenotipificación/métodos , Obesidad/fisiopatología , Delgadez/fisiopatología , Anticuerpos Monoclonales/inmunología , Análisis Discriminante , Humanos , FenotipoRESUMEN
Multicolor Flow Cytometry (MFC)-based gating allows the selection of cellular (pheno)types based on their unique marker expression. Current manual gating practice is highly subjective and may remove relevant information to preclude discovery of cell populations with specific co-expression of multiple markers. Only multivariate approaches can extract such aspects of cell variability from multi-dimensional MFC data. We describe the novel method ECLIPSE (Elimination of Cells Lying in Patterns Similar to Endogeneity) to identify and characterize aberrant cells present in individuals out of homeostasis. ECLIPSE combines dimensionality reduction by Simultaneous Component Analysis with Kernel Density Estimates. A Difference between Densities (DbD) is used to eliminate cells in responder samples that overlap in marker expression with cells of controls. Thereby, subsequent data analyses focus on the immune response-specific cells, leading to more informative and focused models. To prove the power of ECLIPSE, we applied the method to study two distinct datasets: the in vivo neutrophil response induced by systemic endotoxin challenge and in studying the heterogeneous immune-response of asthmatics. ECLIPSE described the well-characterized common response in the LPS challenge insightfully, while identifying slight differences between responders. Also, ECLIPSE enabled characterization of the immune response associated to asthma, where the co-expressions between all markers were used to stratify patients according to disease-specific cell profiles.
Asunto(s)
Asma/inmunología , Biología Computacional/métodos , Endotoxinas/efectos adversos , Citometría de Flujo/métodos , Linfocitos/citología , Adulto , Anciano , Algoritmos , Biomarcadores/metabolismo , Estudios de Casos y Controles , Endotoxinas/inmunología , Femenino , Humanos , Linfocitos/metabolismo , Masculino , Persona de Mediana Edad , Adulto JovenRESUMEN
Multicolour Flow Cytometry (MFC) produces multidimensional analytical data on the quantitative expression of multiple markers on single cells. This data contains invaluable biomedical information on (1) the marker expressions per cell, (2) the variation in such expression across cells, (3) the variability of cell marker expression across samples that (4) may vary systematically between cells collected from donors and patients. Current conventional and even advanced data analysis methods for MFC data explore only a subset of these levels. The Discriminant Analysis of MultiAspect CYtometry (DAMACY) we present here provides a comprehensive view on health and disease responses by integrating all four levels. We validate DAMACY by using three distinct datasets: in vivo response of neutrophils evoked by systemic endotoxin challenge, the clonal response of leukocytes in bone marrow of acute myeloid leukaemia (AML) patients, and the complex immune response in blood of asthmatics. DAMACY provided good accuracy 91-100% in the discrimination between health and disease, on par with literature values. Additionally, the method provides figures that give insight into the marker expression and cell variability for more in-depth interpretation, that can benefit both physicians and biomedical researchers to better diagnose and monitor diseases that are reflected by changes in blood leukocytes.
Asunto(s)
Biomarcadores/análisis , Análisis de Datos , Citometría de Flujo/métodos , Análisis de la Célula Individual , Adulto , Anciano , Asma/patología , Color , Análisis Discriminante , Humanos , Leucemia Mieloide Aguda/patología , Lipopolisacáridos/farmacología , Persona de Mediana Edad , Modelos Biológicos , Fenotipo , Adulto JovenRESUMEN
We have investigated the effect of thermal treatment on the discrimination of pure extra virgin olive oil (EVOO) samples from EVOO samples adulterated with sunflower oil. Two groups of samples were used. One group was analyzed at room temperature (25°C) and the other group was thermally treated in a thermostatic water bath at 75°C for 8h, in contact with air and with light exposure, to favor oxidation. All samples were then measured with synchronous fluorescence spectroscopy. Fluorescence spectra were acquired by varying the excitation wavelength in the region from 250 to 720nm. In order to optimize the differences between excitation and emission wavelengths, four constant differential wavelengths, i.e., 20nm, 40nm, 60nm and 80nm, were tried. Partial least-squares discriminant analysis (PLS-DA) was used to discriminate between pure and adulterated oils. It was found that the 20nm difference was the optimal, at which the discrimination models showed the best results. The best PLS-DA models were those built with the difference spectra (75-25°C), which were able to discriminate pure from adulterated oils at a 2% level of adulteration. Furthermore, PLS regression models were built to quantify the level of adulteration. Again, the best model was the one built with the difference spectra, with a prediction error of 1.75% of adulteration.